MX9207150A - Metodo y composiciones para reducir la resistenciaa multiples farmacos. - Google Patents
Metodo y composiciones para reducir la resistenciaa multiples farmacos.Info
- Publication number
- MX9207150A MX9207150A MX9207150A MX9207150A MX9207150A MX 9207150 A MX9207150 A MX 9207150A MX 9207150 A MX9207150 A MX 9207150A MX 9207150 A MX9207150 A MX 9207150A MX 9207150 A MX9207150 A MX 9207150A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- resistance
- pharmacs
- reduce
- human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80518691A | 1991-12-10 | 1991-12-10 | |
| US98276692A | 1992-12-07 | 1992-12-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9207150A true MX9207150A (es) | 1993-12-01 |
Family
ID=27122756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9207150A MX9207150A (es) | 1991-12-10 | 1992-12-10 | Metodo y composiciones para reducir la resistenciaa multiples farmacos. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0616493A4 (ja) |
| JP (1) | JPH07502274A (ja) |
| CN (1) | CN1076358A (ja) |
| AU (1) | AU3243393A (ja) |
| CA (1) | CA2125279A1 (ja) |
| IL (1) | IL104063A0 (ja) |
| MX (1) | MX9207150A (ja) |
| WO (1) | WO1993011668A1 (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681812A (en) * | 1991-12-10 | 1997-10-28 | Rush Presbyterian-St. Luke's Medical Center | Methods and compositions for reducing multidrug resistance |
| CA2130025A1 (en) * | 1993-08-25 | 1995-02-26 | Robert B. Peery | Method of treating fungal infections |
| WO1995031981A2 (en) * | 1994-05-19 | 1995-11-30 | Rush-Presbyterian-St. Luke's Medical Center | Methods and compositions for reducing multidrug resistance |
| US5922754A (en) * | 1998-10-02 | 1999-07-13 | Abbott Laboratories | Pharmaceutical compositions containing paclitaxel |
| JP2002538224A (ja) * | 1999-03-09 | 2002-11-12 | プロタルガ，インコーポレーテッド | 脂肪酸−抗癌剤複合体およびこの使用 |
| US7235583B1 (en) | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
| WO2000067802A1 (en) * | 1999-05-10 | 2000-11-16 | Protarga, Inc. | Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof |
| DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
| DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
| US4889525A (en) * | 1982-08-17 | 1989-12-26 | Adamantech, Inc. | Sensitization of hypoxic tumor cells and control of growth thereof |
| US4557934A (en) * | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
| US4563351A (en) * | 1983-08-01 | 1986-01-07 | Forsyth Dental Infirmary For Children | Self-gelling therapeutic compositions for topical application |
| SE8601624D0 (sv) * | 1986-04-11 | 1986-04-11 | Haessle Ab | New pharmaceutical preparations |
| US4978622A (en) * | 1986-06-23 | 1990-12-18 | Regents Of The University Of California | Cytophaga-derived immunopotentiator |
| JP2558107B2 (ja) * | 1986-12-18 | 1996-11-27 | 第一製薬株式会社 | 外用剤 |
| US4863968A (en) * | 1987-04-09 | 1989-09-05 | Merrell Dow Pharmaceuticals Inc. | Methods of treating gout with chalcone derivatives |
| US4904697A (en) * | 1987-04-09 | 1990-02-27 | Merrell Dow Pharmaceuticals Inc. | Controlling the growth of certain tumor tissue with chalcone derivatives |
| US4753965A (en) * | 1987-04-09 | 1988-06-28 | Merrell Dow Pharmaceuticals, Inc. | Method of treating multiple sclerosis with chalcone derivatives |
| US4978332A (en) * | 1987-09-28 | 1990-12-18 | Matrix Pharmaceutical, Inc. | Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas |
| US5108989A (en) * | 1990-04-04 | 1992-04-28 | Genentech, Inc. | Method of predisposing mammals to accelerated tissue repair |
-
1992
- 1992-12-09 CA CA002125279A patent/CA2125279A1/en not_active Abandoned
- 1992-12-09 WO PCT/US1992/010563 patent/WO1993011668A1/en not_active Application Discontinuation
- 1992-12-09 EP EP19930900961 patent/EP0616493A4/en not_active Withdrawn
- 1992-12-09 AU AU32433/93A patent/AU3243393A/en not_active Abandoned
- 1992-12-09 JP JP5511010A patent/JPH07502274A/ja active Pending
- 1992-12-10 MX MX9207150A patent/MX9207150A/es unknown
- 1992-12-10 IL IL104063A patent/IL104063A0/xx unknown
- 1992-12-10 CN CN92115397A patent/CN1076358A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU3243393A (en) | 1993-07-19 |
| WO1993011668A1 (en) | 1993-06-24 |
| EP0616493A1 (en) | 1994-09-28 |
| CA2125279A1 (en) | 1993-06-24 |
| EP0616493A4 (en) | 1994-11-09 |
| CN1076358A (zh) | 1993-09-22 |
| JPH07502274A (ja) | 1995-03-09 |
| IL104063A0 (en) | 1993-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68905863D1 (de) | Zusammensetzungen essentieller fettsaeuren. | |
| DE69114498D1 (de) | Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen. | |
| ES2145118T3 (es) | Derivados de acidos grasos y composiciones farmaceuticas que los contienen. | |
| IT1176916B (it) | Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica | |
| ATE236627T1 (de) | Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure | |
| FI970298A (fi) | DHA:n käyttö farmaseuttisena koostumuksena | |
| DE60000133D1 (de) | Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen | |
| PL261349A1 (en) | Method of obtaining an incorporative complex of 7-isopropoxyisoflavone with cyclodextrin | |
| SE8402560L (sv) | Farmaceutisk komposition | |
| ATE75397T1 (de) | Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ. | |
| ATE361066T1 (de) | Polyungesättigen fettsäuren nährungsergänzung | |
| NZ217703A (en) | 2-(2-fluoro-4-biphenylyl) propionic acid compositions | |
| MX9207150A (es) | Metodo y composiciones para reducir la resistenciaa multiples farmacos. | |
| US5246726A (en) | Iron-containing composition and method for treatment of cancer | |
| US5128152A (en) | Iron-containing compositions and method for treating cancer | |
| IE862351L (en) | Pharmaceutical compositions | |
| NO175885C (no) | Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling | |
| ES2009249A6 (es) | Composicion cosmetica regeneradora de la piel a base de algas que contengan selenio. | |
| ES8304058A1 (es) | Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10,14-hexadecapentaenoico. | |
| EP0357646A4 (en) | Treatment of aged skin with oral 13-cis-retinoic acid | |
| BE894860A (fr) | Therapeutique adjuvante par agent progestatif | |
| NO912890D0 (no) | Preparat inneholdende salicylsyre for behandling av hudsykdommer med avskalling. | |
| ATE102934T1 (de) | Fluorierte flavon-essigsaeure. | |
| FR2644460B1 (ja) | ||
| WO1995031981A3 (en) | Methods and compositions for reducing multidrug resistance |